Company news
Neuropace, Inc. news in 2023
Neuropace, Inc.'s news releases, calls and decks from 2023, newest first.
NeuroPace Announces Early Completion of Patient Enrollment in NAUTILUS Pivotal Study
December 20, 2023
NeuroPace to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 18, 2023
NeuroPace to Leverage the Power of its RNS System’s Novel Data Collection, Brain Monitoring and Analysis Capabilities in Groundbreaking Collaboration
December 3, 2023
NeuroPace and the RNS System Showcased at the 77th American Epilepsy Society (AES) Annual Meeting
November 30, 2023
NeuroPace to Present at the Piper Sandler 35th Annual Healthcare Conference
November 20, 2023
NeuroPace Reports Third Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
November 5, 2023
NeuroPace Announces RNS System Enhancements Designed to Streamline Care
October 16, 2023
NeuroPace to Report Third Quarter 2023 Financial Results on November 6, 2023
October 15, 2023
NeuroPace to Participate in 2023 Cantor Fitzgerald Global Healthcare Conference
September 19, 2023
NeuroPace to Participate in Upcoming Investor Conferences
August 23, 2023
NeuroPace Reports Second Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
August 7, 2023
NeuroPace Announces Inducement Grants Under Listing Rule 5635(c)(4) of The Nasdaq Stock Market
July 18, 2023
NeuroPace to Report Second Quarter 2023 Financial Results on August 8, 2023
July 17, 2023
NeuroPace Announces CEO Transition
June 27, 2023
NeuroPace Announces Addition of Kelley Nicholas as Vice President, Sales
May 23, 2023
NeuroPace Reports First Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
May 3, 2023
NeuroPace to Report First Quarter 2023 Financial Results on May 4, 2023
April 16, 2023
NeuroPace to Present at the 22nd Annual Needham Virtual Healthcare Conference
April 2, 2023
NeuroPace Reports Fourth Quarter & Full Year 2022 Financial Results
March 1, 2023
NeuroPace to Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023
February 9, 2023
NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2022 Revenue and Appoints Dr. Uri Geiger to Board of Directors
January 8, 2023
Calls in 2023
Decks in 2023
- JP Morgan Healthcare Conference 2023
Conference · 20 slides · Jan 9, 2023